South Dakota’s hydroxychloroquine trial discontinued

The statewide hydroxychloroquine trial, a collaboration among Sanford Health, Avera Health and Monument Health, and sponsored by the state of South Dakota, has been discontinued.

9 months ago

Health systems, state will partner to offer antimalarial drug to qualifying patients, study participants

COVID-19 patients whose physicians agree they could benefit from the antimalarial drug hydroxychloroquine will be able to access the drug at all major health systems in South Dakota, and those who have been exposed might be eligible to take the drug as part of a controlled study led by Sanford Health.

11 months ago

News Tip

Have a business news item to share with us?

Scroll to top